Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Alkermes - 34 Year Stock Price History | ALKS

Historical daily share price chart and data for Alkermes since 1991 adjusted for splits and dividends. The latest closing stock price for Alkermes as of June 11, 2025 is 31.20.
  • The all-time high Alkermes stock closing price was 98.06 on March 01, 2000.
  • The Alkermes 52-week high stock price is 36.45, which is 16.8% above the current share price.
  • The Alkermes 52-week low stock price is 22.90, which is 26.6% below the current share price.
  • The average Alkermes stock price for the last 52 weeks is 29.20.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Alkermes Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 31.3630 28.7500 36.0000 26.5900 31.2000 8.48%
2024 27.0795 28.6200 32.5600 23.0100 28.7600 3.68%
2023 28.1991 25.8700 33.6300 23.3700 27.7400 6.16%
2022 25.8508 24.1500 31.8700 21.9400 26.1300 12.34%
2021 24.3681 19.7400 32.1300 18.2100 23.2600 16.59%
2020 17.6379 19.7600 22.1000 13.0600 19.9500 -2.21%
2019 25.4201 29.1100 37.3300 17.2900 20.4000 -30.87%
2018 45.9912 55.2200 67.2600 27.9400 29.5100 -46.08%
2017 54.8202 56.1000 61.6600 47.6900 54.7300 -1.53%
2016 45.4797 74.8300 75.2700 29.0500 55.5800 -29.98%
2015 66.3881 58.2400 80.1400 55.0800 79.3800 35.55%
2014 47.3686 40.2400 58.8800 40.0700 58.5600 44.02%
2013 30.2679 19.2800 41.1200 19.2800 40.6600 119.55%
2012 18.1843 17.3400 20.8800 15.1200 18.5200 6.68%
2011 15.4303 12.5500 19.5200 12.1400 17.3600 41.37%
2010 12.4458 9.7100 15.9200 9.6900 12.2800 30.50%
2009 9.6078 10.7100 13.1300 7.5600 9.4100 -11.64%
2008 12.2138 15.1000 16.8900 6.1000 10.6500 -31.69%
2007 15.7875 13.0900 18.5600 12.7600 15.5900 16.60%
2006 18.9789 20.5200 26.7100 13.1800 13.3700 -30.07%
2005 14.4017 14.0100 19.6600 10.0100 19.1200 35.70%
2004 13.3926 13.9700 16.8600 8.5100 14.0900 4.37%
2003 11.0879 6.6600 15.5600 6.5200 13.5000 115.31%
2002 15.1027 25.7500 30.3400 3.7800 6.2700 -76.21%
2001 26.8796 27.6250 37.1000 17.5000 26.3600 -15.98%
2000 41.5579 25.5000 98.0625 23.6250 31.3750 27.74%
1999 15.7495 11.6875 26.8125 11.4375 24.5625 121.41%
1998 9.9983 9.9375 13.3750 5.3125 11.0938 11.64%
1997 9.5159 11.1875 14.8125 5.1875 9.9375 -14.52%
1996 6.2354 3.7500 12.1250 3.7500 11.6250 192.91%
1995 2.4000 1.0313 4.3125 1.0000 3.9688 273.53%
1994 2.4714 3.6875 4.5000 1.0625 1.0625 -69.64%
1993 4.1401 4.5000 5.5000 3.1250 3.5000 -17.65%
1992 6.0672 9.0000 14.1875 2.7500 4.2500 -52.78%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.122B $1.558B
Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major therapeutic areas. Alkermes holds a diversified product portfolio and a promising pipeline of candidates targeting major central nervous system (CNS) disorders including schizophrenia, depression, addiction and multiple sclerosis. Alkermes derives revenues on net sales of its proprietary products: Vivitrol & Aristada, and manufacturing and/or royalty revenues on net sales of products commercialized by the company's partners. These include Risperdal Consta, Invega Sustenna/Xeplion, Invega Trinza/Trevicta, Ampyra/Fampyra and Bydureon. Interesting late-stage candidate in the company's pipeline include nemvaleukin alfa developed for treating advanced solid tumors. Its proprietary drugs are Vivitrol & Aristada.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $228.967B 17.09
Amgen (AMGN) United States $157.779B 14.13
Gilead Sciences (GILD) United States $136.944B 14.22
Vertex Pharmaceuticals (VRTX) United States $115.949B 0.00
Bristol Myers Squibb (BMY) United States $101.693B 6.81
GSK (GSK) United Kingdom $84.648B 10.12
CSL (CSLLY) Australia $77.172B 0.00
Regeneron Pharmaceuticals (REGN) United States $56.523B 13.72
Alnylam Pharmaceuticals (ALNY) United States $39.437B 0.00
Argenex SE (ARGX) Netherlands $35.137B 95.91
BioNTech SE (BNTX) Germany $25.696B 0.00
Biogen (BIIB) United States $19.853B 8.56
Royalty Pharma (RPRX) United States $18.880B 7.98
Insmed (INSM) United States $16.562B 0.00
Genmab (GMAB) Denmark $14.646B 16.43
Genmab (GNMSF) Denmark $14.413B 14.74
Illumina (ILMN) United States $13.927B 26.42
Incyte (INCY) United States $13.563B 103.04
Exelixis (EXEL) United States $11.596B 19.68
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
BioMarin Pharmaceutical (BMRN) United States $11.023B 17.91
Moderna (MRNA) United States $10.705B 0.00
Exact Sciences (EXAS) United States $10.598B 0.00
Ascendis Pharma (ASND) Denmark $10.529B 0.00
QIAGEN (QGEN) Netherlands $10.274B 19.99
Blueprint Medicines (BPMC) United States $8.265B 0.00
Bio-Techne Corp (TECH) United States $8.058B 30.06
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.999B 0.00
Revolution Medicines (RVMD) United States $7.820B 0.00
Roivant Sciences (ROIV) United Kingdom $7.729B 0.00
Repligen (RGEN) United States $7.465B 83.57
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.388B 0.00
Legend Biotech (LEGN) United States $6.917B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.838B 6.71
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.626B 12.68
TG Therapeutics (TGTX) United States $6.260B 164.29
Guardant Health (GH) United States $6.206B 0.00
Telix Pharmaceuticals (TLX) Australia $5.839B 0.00
Nuvalent (NUVL) United States $5.706B 0.00
Axsome Therapeutics (AXSM) United States $5.412B 0.00
Zealand Pharma (ZLDPF) Denmark $5.382B 0.00
ADMA Biologics Inc (ADMA) United States $4.980B 37.25
Vaxcyte (PCVX) United States $4.799B 0.00
Zai Lab (ZLAB) China $4.413B 0.00
Akero Therapeutics (AKRO) United States $4.346B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.286B 0.00
Cytokinetics (CYTK) United States $4.125B 0.00
PTC Therapeutics (PTCT) United States $4.101B 7.14
Avidity Biosciences (RNA) United States $4.052B 0.00
Krystal Biotech (KRYS) United States $3.994B 30.78
Merus (MRUS) Netherlands $3.907B 0.00
Sarepta Therapeutics (SRPT) United States $3.840B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.715B 32.65
CRISPR Therapeutics AG (CRSP) Switzerland $3.708B 0.00
Metsera (MTSR) United States $3.687B 0.00
Arcellx (ACLX) United States $3.671B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.546B 0.00
SpringWorks Therapeutics (SWTX) United States $3.522B 0.00
Protagonist Therapeutics (PTGX) United States $3.494B 75.16
Viking Therapeutics (VKTX) United States $3.273B 0.00
Scholar Rock Holding (SRRK) United States $3.268B 0.00
Kymera Therapeutics (KYMR) United States $3.165B 0.00
Alvotech (ALVO) Luxembourg $3.126B 17.88
MoonLake Immunotherapeutics (MLTX) Switzerland $2.949B 0.00
ImmunityBio (IBRX) United States $2.948B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.936B 0.00
Immunovant (IMVT) United States $2.861B 0.00
Ascentage Pharma Group - (AAPG) China $2.605B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.468B 0.00
Apellis Pharmaceuticals (APLS) United States $2.461B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.426B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.344B 0.00
Vericel (VCEL) United States $2.301B 1523.33
Bavarian Nordic (BVNRY) Denmark $2.254B 11.91
Denali Therapeutics (DNLI) United States $2.217B 0.00
Ligand Pharmaceuticals (LGND) United States $2.188B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.172B 0.00
CG Oncology (CGON) United States $2.095B 0.00
Twist Bioscience (TWST) United States $2.064B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.059B 13.68
NovoCure (NVCR) Jersey $2.049B 0.00
Agios Pharmaceuticals (AGIO) United States $1.999B 0.00
IDEAYA Biosciences (IDYA) United States $1.982B 0.00
Belite Bio (BLTE) United States $1.948B 0.00
Certara (CERT) United States $1.945B 36.33
Apogee Therapeutics (APGE) United States $1.935B 0.00
Amicus Therapeutics (FOLD) United States $1.881B 203.67
Disc Medicine (IRON) United States $1.838B 0.00
Beam Therapeutics (BEAM) United States $1.818B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.805B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.730B 0.00
Biohaven (BHVN) United States $1.714B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.656B 0.00
Edgewise Therapeutics (EWTX) United States $1.625B 0.00
Mesoblast (MESO) Australia $1.624B 0.00
BGM Group (BGM) China $1.591B 0.00
Adaptive Biotechnologies (ADPT) United States $1.589B 0.00
Janux Therapeutics (JANX) United States $1.553B 0.00
GRAIL (GRAL) United States $1.516B 0.00
89BIO (ETNB) United States $1.501B 0.00
Vera Therapeutics (VERA) United States $1.443B 0.00
Celldex Therapeutics (CLDX) United States $1.389B 0.00
ANI Pharmaceuticals (ANIP) United States $1.362B 14.03
Travere Therapeutics (TVTX) United States $1.344B 0.00
Liquidia Technologies (LQDA) United States $1.281B 0.00
Viridian Therapeutics (VRDN) United States $1.258B 0.00
Dynavax Technologies (DVAX) United States $1.252B 74.50
Structure Therapeutics (GPCR) United States $1.252B 0.00
Anbio Biotechnology (NNNN) Germany $1.246B 0.00
MannKind (MNKD) United States $1.191B 24.50
Novavax (NVAX) United States $1.166B 2.72
Pacira BioSciences (PCRX) United States $1.151B 10.96
Spyre Therapeutics (SYRE) United States $1.119B 0.00
WAVE Life Sciences (WVE) Singapore $1.114B 0.00
Niagen Bioscience (NAGE) United States $1.065B 150.22
Arcus Biosciences (RCUS) United States $1.061B 0.00
Mineralys Therapeutics (MLYS) United States $1.045B 0.00
Geron (GERN) United States $1.019B 0.00
CorMedix Inc (CRMD) United States $1.010B 67.68
NeoGenomics (NEO) United States $1.009B 0.00
Nurix Therapeutics (NRIX) United States $0.975B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.967B 0.00
MiMedx (MDXG) United States $0.964B 23.32
CureVac (CVAC) Germany $0.958B 4.64
Pharvaris (PHVS) Netherlands $0.948B 0.00
Praxis Precision Medicines (PRAX) United States $0.934B 0.00
Zymeworks (ZYME) United States $0.909B 0.00
AbCellera Biologics (ABCL) Canada $0.901B 0.00
UniQure (QURE) Netherlands $0.895B 0.00
Intellia Therapeutics (NTLA) United States $0.877B 0.00
Oculis Holding AG (OCS) Switzerland $0.864B 0.00
Nuvation Bio (NUVB) United States $0.861B 0.00
Cogent Biosciences (COGT) United States $0.845B 0.00
Gyre Therapeutics (GYRE) United States $0.844B 225.00
ArriVent BioPharma (AVBP) United States $0.838B 0.00
Immunome (IMNM) United States $0.833B 0.00
Sionna Therapeutics (SION) United States $0.806B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Iovance Biotherapeutics (IOVA) United States $0.795B 0.00
LENZ Therapeutics (LENZ) United States $0.790B 0.00
Pharming Group (PHAR) Netherlands $0.784B 0.00
Replimune (REPL) United States $0.781B 0.00
Trevi Therapeutics (TRVI) United States $0.764B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Vir Biotechnology (VIR) United States $0.749B 0.00
Immatics (IMTX) Germany $0.722B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.708B 0.00
AnaptysBio (ANAB) United States $0.704B 0.00
Anavex Life Sciences (AVXL) United States $0.693B 0.00
Oric Pharmaceuticals (ORIC) United States $0.693B 0.00
Bicara Therapeutics (BCAX) United States $0.686B 0.00
Arbutus Biopharma (ABUS) United States $0.680B 0.00
GH Research (GHRS) Ireland $0.668B 0.00
Sana Biotechnology (SANA) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.634B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.626B 0.00
Upstream Bio (UPB) United States $0.623B 0.00
Stoke Therapeutics (STOK) United States $0.620B 14.38
Autolus Therapeutics (AUTL) United Kingdom $0.620B 0.00
Dianthus Therapeutics (DNTH) United States $0.603B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.598B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.596B 0.00
Kura Oncology (KURA) United States $0.590B 0.00
Arvinas (ARVN) United States $0.571B 0.00
Tyra Biosciences (TYRA) United States $0.569B 0.00
Maze Therapeutics (MAZE) United States $0.564B 0.00
Keros Therapeutics (KROS) United States $0.558B 0.00
MeiraGTx Holdings (MGTX) United States $0.551B 0.00
Cullinan Therapeutics (CGEM) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Castle Biosciences (CSTL) United States $0.521B 35.37
Zenas BioPharma (ZBIO) United States $0.500B 0.00
Abivax SA (ABVX) France $0.499B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.498B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
REGENXBIO (RGNX) United States $0.492B 0.00
Fortrea Holdings (FTRE) United States $0.490B 13.52
ATyr Pharma (ATYR) United States $0.490B 0.00
Celcuity (CELC) United States $0.489B 0.00
Tango Therapeutics (TNGX) United States $0.485B 0.00
Myriad Genetics (MYGN) United States $0.482B 0.00
Rapport Therapeutics (RAPP) United States $0.480B 0.00
Tectonic Therapeutic (TECX) United States $0.470B 0.00
PureTech Health (PRTC) United States $0.459B 0.00
Septerna (SEPN) United States $0.458B 0.00
Erasca (ERAS) United States $0.456B 0.00
Precigen (PGEN) United States $0.455B 0.00
Cytek Biosciences (CTKB) United States $0.440B 0.00
Sage Therapeutics (SAGE) United States $0.438B 0.00
Benitec Biopharma (BNTC) United States $0.425B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.421B 0.00
Eton Pharmaceuticals (ETON) United States $0.421B 0.00
Humacyte (HUMA) United States $0.414B 0.00
Kamada (KMDA) Israel $0.402B 24.10
Northwest Biotherapeutics (NWBO) United States $0.395B 0.00
Absci (ABSI) United States $0.387B 0.00
ITeos Therapeutics (ITOS) United States $0.384B 0.00
MBX Biosciences (MBX) United States $0.383B 0.00
Rezolute (RZLT) United States $0.375B 0.00
Solid Biosciences (SLDB) United States $0.374B 0.00
Fulcrum Therapeutics (FULC) United States $0.372B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Emergent Biosolutions (EBS) United States $0.366B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.364B 0.00
Terns Pharmaceuticals (TERN) United States $0.355B 0.00
Aura Biosciences (AURA) United States $0.350B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.350B 0.00
Inventiva S.A (IVA) France $0.349B 0.00
Compass Therapeutics (CMPX) United States $0.347B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.337B 0.00
Verastem (VSTM) United States $0.336B 0.00
Abeona Therapeutics (ABEO) United States $0.330B 0.00
Ocugen (OCGN) United States $0.330B 0.00
Cidara Therapeutics (CDTX) United States $0.328B 0.00
Urogen Pharma (URGN) United States $0.325B 0.00
Astria Therapeutics (ATXS) United States $0.322B 0.00
Allogene Therapeutics (ALLO) United States $0.319B 0.00
Alpha Teknova (TKNO) United States $0.316B 0.00
Entrada Therapeutics (TRDA) United States $0.313B 10.20
Monte Rosa Therapeutics (GLUE) United States $0.312B 63.50
Neurogene (NGNE) United States $0.308B 0.00
XOMA Royalty (XOMA) United States $0.299B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.295B 0.00
Candel Therapeutics (CADL) United States $0.293B 0.00
Palvella Therapeutics (PVLA) United States $0.290B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.290B 0.00
Annexon (ANNX) United States $0.290B 0.00
Olema Pharmaceuticals (OLMA) United States $0.288B 0.00
Cardiff Oncology (CRDF) United States $0.286B 0.00
Gossamer Bio (GOSS) United States $0.284B 0.00
Prothena (PRTA) Ireland $0.283B 0.00
Cartesian Therapeutics (RNAC) United States $0.280B 0.00
Atea Pharmaceuticals (AVIR) United States $0.276B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.275B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Amarin (AMRN) Ireland $0.265B 0.00
Foghorn Therapeutics (FHTX) United States $0.258B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Aardvark Therapeutics (AARD) United States $0.255B 0.00
Lifecore Biomedical (LFCR) United States $0.254B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.253B 0.00
DBV Technologies S.A (DBVT) France $0.247B 0.00
Instil Bio (TIL) United States $0.246B 0.00
MaxCyte (MXCT) United States $0.246B 0.00
Tvardi Therapeutics (TVRD) United States $0.244B 0.00
Third Harmonic Bio (THRD) United States $0.239B 0.00
BioStem Technologies (BSEM) $0.234B 9.54
Y-mAbs Therapeutics (YMAB) United States $0.231B 0.00
Adherex Technologies (FENC) United States $0.229B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Semper Paratus Acquisition (TVGN) United States $0.228B 0.00
Design Therapeutics (DSGN) United States $0.228B 0.00
ScPharmaceuticals (SCPH) United States $0.225B 0.00
Kodiak Sciences (KOD) United States $0.223B 0.00
Inhibrx Biosciences (INBX) United States $0.222B 0.13
AC Immune (ACIU) Switzerland $0.221B 0.00
CytomX Therapeutics (CTMX) United States $0.218B 5.62
I-Mab (IMAB) United States $0.216B 0.00
Adocia (ADOCY) France $0.213B 0.00
GENFIT S.A (GNFT) France $0.212B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
Monopar Therapeutics (MNPR) United States $0.211B 0.00
Prime Medicine (PRME) United States $0.204B 0.00
Codexis (CDXS) United States $0.202B 0.00
Bright Minds Biosciences (DRUG) United States $0.199B 0.00
Voyager Therapeutics (VYGR) United States $0.191B 0.00
Fate Therapeutics (FATE) United States $0.191B 0.00
Ventyx Biosciences (VTYX) United States $0.189B 0.00
Nuvectis Pharma (NVCT) United States $0.188B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.186B 0.00
Innate Pharma S.A (IPHA) France $0.183B 0.00
Sagimet Biosciences (SGMT) United States $0.182B 0.00
INmune Bio (INMB) United States $0.181B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.179B 0.00
Puma Biotechnology (PBYI) United States $0.179B 4.68
DiaMedica Therapeutics (DMAC) United States $0.177B 0.00
Editas Medicine (EDIT) United States $0.176B 0.00
Actuate Therapeutics (ACTU) United States $0.169B 0.00
Anika Therapeutics (ANIK) United States $0.166B 0.00
Neumora Therapeutics (NMRA) United States $0.165B 0.00
EnGene Holdings (ENGN) Canada $0.164B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.160B 0.00
Compugen (CGEN) Israel $0.160B 0.00
Spero Therapeutics (SPRO) United States $0.159B 0.00
Alector (ALEC) United States $0.159B 0.00
Alumis (ALMS) United States $0.159B 0.00
Rapt Therapeutics (RAPT) United States $0.157B 0.00
BioAge Labs (BIOA) United States $0.157B 0.00
Kyverna Therapeutics (KYTX) United States $0.156B 0.00
Galena Biopharma (SLS) United States $0.154B 0.00
Molecular Partners AG (MOLN) Switzerland $0.149B 0.00
Agenus (AGEN) United States $0.147B 0.00
23andMe Holding (MEHCQ) United States $0.145B 0.00
Alpha Cognition (ACOG) Canada $0.145B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.143B 0.00
Nkarta (NKTX) United States $0.141B 0.00
Black Diamond Therapeutics (BDTX) United States $0.140B 41.00
Seer (SEER) United States $0.131B 0.00
Greenwich LifeSciences (GLSI) United States $0.129B 0.00
Elicio Therapeutics (ELTX) United States $0.128B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.128B 0.00
Contineum Therapeutics (CTNM) United States $0.126B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.121B 0.00
Sangamo Therapeutics (SGMO) United States $0.120B 0.00
Cabaletta Bio (CABA) United States $0.119B 0.00
BioHarvest Sciences (BHST) Canada $0.119B 0.00
TuHURA Biosciences (HURA) United States $0.119B 0.00
Theratechnologies (THTX) Canada $0.119B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.117B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
Caribou Biosciences (CRBU) United States $0.113B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.112B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
C4 Therapeutics (CCCC) United States $0.111B 0.00
Invivyd (IVVD) United States $0.109B 0.00
BeyondSpring (BYSI) United States $0.101B 0.00
Genelux (GNLX) United States $0.101B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
Entera Bio (ENTX) Israel $0.097B 0.00
TScan Therapeutics (TCRX) United States $0.096B 0.00
Biomea Fusion (BMEA) United States $0.095B 0.00
Nautilus Biotechnology (NAUT) United States $0.095B 0.00
Pliant Therapeutics (PLRX) United States $0.095B 0.00
Coya Therapeutics (COYA) United States $0.094B 0.00
Whitehawk Therapeutics (WHWK) United States $0.094B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.094B 0.00
Coherus BioSciences (CHRS) United States $0.093B 0.00
Climb Bio (CLYM) United States $0.093B 0.00
Adagene (ADAG) China $0.092B 0.00
Citius Oncology (CTOR) United States $0.092B 0.00
XBiotech (XBIT) United States $0.089B 0.00
Zura Bio (ZURA) United States $0.088B 0.00
Jasper Therapeutics (JSPR) United States $0.087B 0.00
Immunic (IMUX) United States $0.085B 0.00
Inovio Pharmaceuticals (INO) United States $0.083B 0.00
Elutia (ELUT) United States $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Forte Biosciences (FBRX) United States $0.081B 0.00
Senti Biosciences (SNTI) United States $0.079B 0.00
Cellectis S.A (CLLS) France $0.078B 0.00
Immuneering (IMRX) United States $0.078B 0.00
PDS Biotechnology (PDSB) United States $0.077B 0.00
TELA Bio (TELA) United States $0.076B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.074B 0.00
Skye Bioscience (SKYE) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Seres Therapeutics (MCRB) United States $0.072B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.071B 0.00
Alto Neuroscience (ANRO) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.071B 0.00
OKYO Pharma (OKYO) $0.070B 0.00
Ikena Oncology (IKNA) United States $0.070B 0.00
MediciNova (MNOV) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Adicet Bio (ACET) United States $0.068B 0.00
CervoMed (CRVO) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.067B 0.00
Akoya Biosciences (AKYA) United States $0.066B 0.00
Renovaro (RENB) United States $0.065B 0.00
Repare Therapeutics (RPTX) Canada $0.063B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Fortress Biotech (FBIO) United States $0.062B 0.00
Opus Genetics (IRD) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Exicure (XCUR) United States $0.061B 0.00
Werewolf Therapeutics (HOWL) United States $0.060B 0.00
Adverum Biotechnologies (ADVM) United States $0.058B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
Precision BioSciences (DTIL) United States $0.058B 0.00
Kalaris Therapeutics (KLRS) United States $0.058B 0.00
InflaRx (IFRX) Germany $0.056B 0.00
Annovis Bio (ANVS) United States $0.056B 0.00
Shattuck Labs (STTK) United States $0.056B 0.00
Applied Therapeutics (APLT) United States $0.055B 0.00
Quince Therapeutics (QNCX) United States $0.055B 0.00
Atara Biotherapeutics (ATRA) United States $0.054B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Mersana Therapeutics (MRSN) United States $0.051B 0.00
Artiva Biotherapeutics (ARTV) United States $0.051B 0.00
PepGen (PEPG) United States $0.049B 0.00
RenovoRx (RNXT) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Celularity (CELU) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.045B 0.00
Aligos Therapeutics (ALGS) United States $0.045B 0.00
Connect Biopharma Holdings (CNTB) United States $0.044B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Scilex Holding (SCLX) United States $0.042B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.041B 0.00
OnKure Therapeutics (OKUR) United States $0.040B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
Quantum Biopharma (QNTM) Canada $0.039B 0.00
Clene (CLNN) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Oncolytics Biotech (ONCY) Canada $0.037B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
FibroBiologics (FBLG) United States $0.036B 0.00
CAMP4 Therapeutics (CAMP) United States $0.035B 0.00
Kezar Life Sciences (KZR) United States $0.034B 0.00
Rani Therapeutics Holdings (RANI) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Passage Bio (PASG) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.030B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.029B 0.00
Vor Biopharma (VOR) $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
Generation Bio (GBIO) United States $0.029B 0.00
Imunon (IMNN) United States $0.028B 0.00
BioAtla (BCAB) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
ABVC BioPharma (ABVC) United States $0.028B 0.00
Gelteq (GELS) Australia $0.028B 0.00
Curis (CRIS) United States $0.026B 0.00
CalciMedica (CALC) United States $0.026B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Ovid Therapeutics (OVID) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Cingulate (CING) United States $0.021B 0.00
X4 Pharmaceuticals (XFOR) United States $0.021B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Femasys (FEMY) United States $0.020B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.020B 0.00
Advanced Biomed (ADVB) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Leap Therapeutics (LPTX) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Abpro Holdings (ABP) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Rallybio (RLYB) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
NextCure (NXTC) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
UNITY Biotechnology (UBX) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Evogene (EVGN) Israel $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
Eyenovia (EYEN) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
IN8bio (INAB) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Holding� (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00